title: Structure-informed design of an enzymatically inactive vaccine component for group A Streptococcus.
abstract: Streptococcus pyogenes (group A Streptococcus [GAS]) causes ~700 million human infections/year, resulting in >500,000 deaths. There is no commercial GAS vaccine available. The GAS surface protein arginine deiminase (ADI) protects mice against a lethal challenge. ADI is an enzyme that converts arginine to citrulline and ammonia. Administration of a GAS vaccine preparation containing wild-type ADI, a protein with inherent enzymatic activity, may present a safety risk. In an approach intended to maximize the vaccine safety of GAS ADI, X-ray crystallography and structural immunogenic epitope mapping were used to inform vaccine design. This study aimed to knock out ADI enzyme activity without disrupting the three-dimensional structure or the recognition of immunogenic epitopes. We determined the crystal structure of ADI at 2.5 Å resolution and used it to select a number of amino acid residues for mutagenesis to alanine (D166, E220, H275, D277, and C401). Each mutant protein displayed abrogated activity, and three of the mutant proteins (those with the D166A, H275A, and D277A mutations) possessed a secondary structure and oligomerization state equivalent to those of the wild type, produced high-titer antisera, and avoided disruption of B-cell epitopes of ADI. In addition, antisera raised against the D166A and D277A mutant proteins bound to the GAS cell surface. The inactivated D166A and D277A mutant ADIs are ideal for inclusion in a GAS vaccine preparation. There is no human ortholog of ADI, and we confirm that despite limited structural similarity in the active-site region to human peptidyl ADI 4 (PAD4), ADI does not functionally mimic PAD4 and antiserum raised against GAS ADI does not recognize human PAD4.
  
  
  OBJECTIVE
  We present an example of structural biology informing human vaccine design. We previously showed that the administration of the enzyme arginine deiminase (ADI) to mice protected the mice against infection with multiple GAS serotypes. In this study, we determined the structure of GAS ADI and used this information to improve the vaccine safety of GAS ADI. Catalytically inactive mutant forms of ADI retained structure, recognition by antisera, and immunogenic epitopes, rendering them ideal for inclusion in GAS vaccine preparations. This example of structural biology informing vaccine design may underpin the formulation of a safe and efficacious GAS vaccine.
authors.affiliation: School of Chemistry and Molecular Biosciences, Australian Infectious Diseases Research Centre, University of Queensland, St. Lucia, Qld., Australia.
authors.forename: Anna
authors.initials: A
authors.lastname: Henningham
authors.forename: Daniel J
authors.initials: DJ
authors.lastname: Ericsson
authors.forename: Karla
authors.initials: K
authors.lastname: Langer
authors.forename: Lachlan W
authors.initials: LW
authors.lastname: Casey
authors.forename: Blagojce
authors.initials: B
authors.lastname: Jovcevski
authors.forename: G Singh
authors.initials: GS
authors.lastname: Chhatwal
authors.forename: J Andrew
authors.initials: JA
authors.lastname: Aquilina
authors.forename: Michael R
authors.initials: MR
authors.lastname: Batzloff
authors.forename: Bostjan
authors.initials: B
authors.lastname: Kobe
authors.forename: Mark J
authors.initials: MJ
authors.lastname: Walker
mesh_terms: D019943:Amino Acid Substitution; D000818:Animals; D000907:Antibodies, Bacterial / Q000097:blood; D000942:Antigens, Bacterial / Q000737:chemistry* / Q000235:genetics / Q000276:immunology / Q000378:metabolism*; D018360:Crystallography, X-Ray; D018604:Epitope Mapping; D006801:Humans; D006867:Hydrolases / Q000737:chemistry* / Q000235:genetics / Q000276:immunology / Q000378:metabolism*; D051379:Mice; D008807:Mice, Inbred BALB C; D008958:Models, Molecular; D016297:Mutagenesis, Site-Directed; D050505:Mutant Proteins / Q000737:chemistry / Q000235:genetics / Q000276:immunology / Q000378:metabolism; D011487:Protein Conformation; D055503:Protein Multimerization; D022541:Streptococcal Vaccines / Q000737:chemistry* / Q000235:genetics / Q000276:immunology / Q000378:metabolism*; D013297:Streptococcus pyogenes / Q000737:chemistry / Q000201:enzymology* / Q000235:genetics / Q000276:immunology
chemical_list: D000907:Antibodies, Bacterial; D000942:Antigens, Bacterial; D050505:Mutant Proteins; D022541:Streptococcal Vaccines; D006867:Hydrolases
references.citation: Sci Transl Med. 2011 Jul 13;3(91):91ra62
references.pmid: 21753121
references.citation: J Mol Med (Berl). 2012 Oct;90(10):1197-207
references.pmid: 22527883
references.citation: Mol Cell Proteomics. 2012 Jun;11(6):M111.015693
references.pmid: 22286755
references.citation: Acta Crystallogr D Biol Crystallogr. 2010 Jan;66(Pt 1):12-21
references.pmid: 20057044
references.citation: Can J Microbiol. 1998 Nov;44(11):1078-85
references.pmid: 10030002
references.citation: Acta Crystallogr D Biol Crystallogr. 2011 Feb;67(Pt 2):112-8
references.pmid: 21245532
references.citation: Mol Microbiol. 2004 Jan;51(1):123-34
references.pmid: 14651616
references.citation: Acta Crystallogr D Biol Crystallogr. 2010 Feb;66(Pt 2):213-21
references.pmid: 20124702
references.citation: Acta Crystallogr D Biol Crystallogr. 2010 Feb;66(Pt 2):125-32
references.pmid: 20124692
references.citation: Infect Immun. 1998 Jul;66(7):3050-8
references.pmid: 9632565
references.citation: J Appl Crystallogr. 2012 Mar 15;45(Pt 2):342-350
references.pmid: 25484842
references.citation: J Biol Chem. 2008 Mar 7;283(10):6359-66
references.pmid: 18180300
references.citation: Microb Pathog. 2003 Aug;35(2):63-72
references.pmid: 12901845
references.citation: Anal Biochem. 2000 Nov 15;286(2):257-64
references.pmid: 11067748
references.citation: JAMA. 2004 Aug 11;292(6):709-15
references.pmid: 15304468
references.citation: Vaccine. 2009 Aug 6;27(36):4923-9
references.pmid: 19563892
references.citation: Clin Microbiol Infect. 2013 May;19(5):E222-9
references.pmid: 23464795
references.citation: Proc Natl Acad Sci U S A. 2011 Jun 21;108(25):10278-83
references.pmid: 21593422
references.citation: J Immune Based Ther Vaccines. 2008 Oct 31;6:8
references.pmid: 18976486
references.citation: Expert Rev Vaccines. 2009 Dec;8(12):1705-20
references.pmid: 19905872
references.citation: Nat Rev Microbiol. 2011 Sep 16;9(10):724-36
references.pmid: 21921933
references.citation: J Biol Chem. 2005 Oct 7;280(40):34080-7
references.pmid: 16091358
references.citation: Vaccine. 2009 Nov 12;27(48):6799-806
references.pmid: 19729086
references.citation: Proteomics. 2007 Dec;7(24):4488-98
references.pmid: 18072207
references.citation: Clin Infect Dis. 2005 Oct 15;41(8):1114-22
references.pmid: 16163629
references.citation: Proteins. 2007 Feb 15;66(3):740-50
references.pmid: 17080455
references.citation: Biochemistry. 2006 Jan 31;45(4):1162-72
references.pmid: 16430212
references.citation: Discov Med. 2012 May;13(72):329-42
references.pmid: 22642914
references.citation: Infect Immun. 1997 Jun;65(6):2080-7
references.pmid: 9169735
references.citation: Curr Top Microbiol Immunol. 2013;368:207-42
references.pmid: 23250780
references.citation: mBio. 2013 Jan 08;4(1):e00387-12
references.pmid: 23300245
references.citation: Infect Immun. 2000 May;68(5):2441-8
references.pmid: 10768929
references.citation: Acta Crystallogr D Biol Crystallogr. 2010 Apr;66(Pt 4):486-501
references.pmid: 20383002
references.citation: Lancet Infect Dis. 2009 Oct;9(10):611-6
references.pmid: 19778763
references.citation: Acta Crystallogr D Biol Crystallogr. 2012 Apr;68(Pt 4):368-80
references.pmid: 22505257
references.citation: J Biol Chem. 2004 Apr 2;279(14):14001-8
references.pmid: 14701825
references.citation: J Appl Crystallogr. 2010 Aug 1;43(Pt 4):669-676
references.pmid: 20648263
references.citation: J Exp Med. 2008 Sep 1;205(9):2085-97
references.pmid: 18710930
references.citation: Biophys J. 2005 Aug;89(2):1237-50
references.pmid: 15923225
references.citation: Science. 2004 Oct 8;306(5694):279-83
references.pmid: 15345777
references.citation: Clin Microbiol Rev. 2000 Jul;13(3):470-511
references.pmid: 10885988
references.citation: J Appl Crystallogr. 2007 Aug 1;40(Pt 4):658-674
references.pmid: 19461840
references.citation: Biochemistry. 2006 Oct 3;45(39):11727-36
references.pmid: 17002273
references.citation: Structure. 2004 Apr;12(4):657-67
references.pmid: 15062088
references.citation: J Biol Chem. 2009 Jun 19;284(25):17129-17137
references.pmid: 19363026
references.citation: Environ Microbiol. 2009 Feb;11(2):432-45
references.pmid: 19196274
references.citation: Appl Environ Microbiol. 1995 Dec;61(12):4494-6
references.pmid: 8534118